The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
One hundred years of schizophrenia: a meta-analysis of the outcome literature
Abstract
OBJECTIVE: This study was undertaken to assess the twentieth-century literature on outcome in schizophrenia for historical trends that might be associated with changes in diagnostic and therapeutic practice and to test the hypothesis that both improved biological treatment and changes in diagnostic criteria have influenced outcome. METHOD: Meta-analysis of the international literature on outcome in schizophrenia or dementia praecox from 1895 to 1992 identified 821 studies; 320 of these, with 51,800 subjects in 368 cohorts, met the inclusion criteria for the study. RESULTS: Only 40.2% of patients were considered improved after follow-ups averaging 5.6 years (range = 1-40). Outcome was significantly better when patients were diagnosed according to systems with broad criteria (46.5% were improved) or undefined criteria (41.0% were improved) rather than narrow criteria (27.3% were improved). The proportion of patients who improved increased significantly after mid-century (for 1956-1985 versus 1895-1955, 48.5% versus 35.4%), probably reflecting improved treatment as well as a broadened concept of schizophrenia. However, in the past decade, the average rate of favorable outcome has declined to 36.4%, perhaps reflecting the re-emergence of narrow diagnostic concepts. CONCLUSIONS: Overall, less than half of patients diagnosed with schizophrenia have shown substantial clinical improvement after follow-up averaging nearly 6 years. Despite considerable gains in improvement rates after mid-century, there has been a decline since the 1970s. These historical changes probably reflect improved treatment, shifts in diagnostic criteria, and selection bias related to changes in health care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Diagnostic Criteria for Use in Psychiatric Research
Feighner, J. P. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,715
Stengel, E. (1960) · BMJ · doi:10.1136/bmj.1.5178.1031-b · Cited by 987
A Controlled Trial of Social Intervention in the Families of Schizophrenic Patients
Leff, J., Kuipers, L., Berkowitz, R., Eberlein-Vries, R., & Sturgeon, D. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.2.121 · Cited by 869 · cited 4×
“It may also be important that most of these studies (19-26) used relatively broad or cross-sectional diagnostic criteria, in contrast to the most recent American diagnostic methods (DSM-III and DSM-III-R), which attend to duration of symptoms and course of illness in what might be termed a "neoKraepelinian" trend.”
Influential(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.6.727 · Cited by 854
The Prediction of Outcome in Schizophrenia: I. Characteristics of Outcome
Strauss, J. S. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750300011002 · Cited by 791
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Publication bias and clinical trials
Dickersin, K., Chan, S., Chalmersx, T. C., Sacks, H. S., & Smith, H. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90155-3 · Cited by 715
Pope, H. G. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310017001 · Cited by 632
Cohen, P. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790230064010 · Cited by 607
Cited by
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Jauhar, S., Johnstone, M., & McKenna, P. J. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01730-x · Cited by 996
Machine Learning Approaches for Clinical Psychology and Psychiatry
Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045037 · Cited by 966
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Jaaskelainen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M., Veijola, J., & Miettunen, J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 907
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Schizophrenia Is a Cognitive Illness: Time for a Change in Focus
Kahn, R. S., & Keefe, R. S. E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.155 · Cited by 825
Bowie, C. R., Reichenberg, A., Patterson, T. L., Heaton, R. K., & Harvey, P. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.418 · Cited by 763
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
TANDON, R., KESHAVAN, M., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.011 · Cited by 720
Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033315 · Cited by 649
Cognitive deficits and functional outcome in schizophrenia
Bowie, C. R., & Harvey, P. D. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.531 · Cited by 647
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Nonsocial and social cognition in schizophrenia: current evidence and future directions
Green, M. F., Horan, W. P., & Lee, J. (2019) · World Psychiatry · doi:10.1002/wps.20624 · Cited by 612
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Vulnerability to psychopathology: A biosocial model.
Zuckerman, M. (1999) · American Psychological Association eBooks · doi:10.1037/10316-000 · Cited by 601
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Gender differences in schizophrenia
Häfner, H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00125-7 · Cited by 565
Operational criteria and factors related to recovery from schizophrenia
Liberman, R. P., Kopelowicz, A., Ventura, J., & Gutkind, D. (2002) · International Review of Psychiatry · doi:10.1080/0954026021000016905 · Cited by 495
Treatment-Resistant Schizophrenia - The Role of Clozapine
Meltzer, H. Y. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113338 · Cited by 491
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Cognitive Impairment in Schizophrenia
Keefe, R. S. E., & Harvey, P. D. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_2 · Cited by 472
Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?
Harvey, P. D., Koren, D., Reichenberg, A., & Bowie, C. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj011 · Cited by 462
Marder, S. R., & Fenton, W. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.010 · Cited by 421
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Lieberman, J. A., Tollefson, G., Tohen, M., Green, A. I., Gur, R. E., Kahn, R., McEvoy, J., Perkins, D., Sharma, T., Zipursky, R., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1396 · Cited by 404
Correll, C. U., Rummel-Kluge, C., Corves, C., Kane, J. M., & Leucht, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn018 · Cited by 397
Cognitive function in schizophrenia
Sharma, T., & Antonova, L. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00084-9 · Cited by 367
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Neil, S. T., Kilbride, M., Pitt, L., Nothard, S., Welford, M., Sellwood, W., & Morrison, A. P. (2009) · Psychosis · doi:10.1080/17522430902913450 · Cited by 362
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Lieberman, J. A., Phillips, M., Gu, H., Stroup, S., Zhang, P., Kong, L., Ji, Z., Koch, G., & Hamer, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300157 · Cited by 345
Treatment-Resistant Schizophrenia
Elkis, H. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.001 · Cited by 338
Harvey, P. D., Howanitz, E., Parrella, M., White, L., Davidson, M., Mohs, R. C., Hoblyn, J., & Davis, K. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1080 · Cited by 338
Lally, J., Ajnakina, O., Stubbs, B., Cullinane, M., Murphy, K. C., Gaughran, F., & Murray, R. M. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201475 · Cited by 335
A systematic review of longitudinal outcome studies of first-episode psychosis
MENEZES, N. M., ARENOVICH, T., & ZIPURSKY, R. B. (2006) · Psychological Medicine · doi:10.1017/s0033291706007951 · Cited by 333
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guide, Falkai, P., Wobrock, T., Lieberman, J., et al. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 331
Peet, M., & Horrobin, D. F. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00048-6 · Cited by 329
Recovery and Severe Mental Illness: Description and Analysis
Drake, R. E., & Whitley, R. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900502 · Cited by 322
The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
Guloksuz, S., & van Os, J. (2018) · Psychological Medicine · doi:10.1017/s0033291717001775 · Cited by 325
Fenton, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R., & Knable, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2071 · Cited by 323
The Varied Outcomes of Schizophrenia
Davidson, L., & McGlashan, T. H. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200105 · Cited by 308
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Green, M. F. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14074su1c.02 · Cited by 287
Psychosocial Treatment for First-Episode Psychosis: A Research Update
Penn, D. L., Waldheter, E. J., Perkins, D. O., Mueser, K. T., & Lieberman, J. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2220 · Cited by 286
Haloperidol alone or in combination for acute mania
Cipriani, A., Rendell, J. M., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004362.pub2 · Cited by 285
Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance
Bowie, C. R., & Harvey, P. D. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.05.004 · Cited by 280
Questioning an Axiom: Better Prognosis for Schizophrenia in the Developing World?
Cohen, A., Patel, V., Thara, R., & Gureje, O. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm105 · Cited by 276
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Psychosocial Treatments to Promote Functional Recovery in Schizophrenia
Kern, R. S., Glynn, S. M., Horan, W. P., & Marder, S. R. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn177 · Cited by 267
Neurocognition: Clinical and Functional Outcomes in Schizophrenia
Lepage, M., Bodnar, M., & Bowie, C. R. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900103 · Cited by 266
Cognition in schizophrenia: Past, present, and future
Green, M. F., & Harvey, P. D. (2014) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2014.02.001 · Cited by 258
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
Carbon, M., & Correll, C. U. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mcarbon · Cited by 257
A systematic review of the long-term outcome of early onset schizophrenia
Clemmensen, L., Vernal, D. L., & Steinhausen, H.-C. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-150 · Cited by 257
Roth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
Marital and Labor Market Status in the Long Run in Schizophrenia
Agerbo, E., Byrne, M., Eaton, W. W., & Mortensen, P. B. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.28 · Cited by 254
An Exploratory Analysis of Correlates of Recovery
Resnick, S. G., Rosenheck, R. A., & Lehman, A. F. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.5.540 · Cited by 251
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
Morgan, C., Lappin, J., Heslin, M., Donoghue, K., Lomas, B., Reininghaus, U., Onyejiaka, A., Croudace, T., Jones, P. B., Murray, R. M., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000282 · Cited by 248
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Does Lithium Treatment Still Work?: Evidence of Stable Responses Over Three Decades
Baldessarini, R. J., & Tondo, L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.187 · Cited by 164
Self-citationHarvey, P. D., Rabinowitz, J., Eerdekens, M., & Davidson, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1888 · Cited by 161
Long-Term Diagnostic Stability and Outcome in Recent First-Episode Cohort Studies of Schizophrenia
Bromet, E. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi030 · Cited by 129
Schizophrenia and Older Adults: An Overview: Directions for Research and Policy
Cohen, C. I., Cohen, G. D., Blank, K., Gaitz, C., Katz, I. R., Leuchter, A., Maletta, G., Meyers, B., Sakauye, K., & Shamoian, C. (2000) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200002000-00003 · Cited by 112
Peet, M. (2003) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.020 · Cited by 103
People with schizophrenia and their families: Fifteen-year outcome
Brown, S., & Birtwistle, J. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.2.139 · Cited by 91
Neeleman, J. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.1.154 · Cited by 79
Evidence-Based Psychotherapy for Schizophrenia
Dickerson, F. B., & Lehman, A. F. (2011) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e318225ee78 · Cited by 63
Taylor, M., & Jauhar, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319870033 · Cited by 51
Yildiz, M., Veznedaroglu, B., Eryavuz, A., & Kayahan, B. (2004) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500410005595 · Cited by 51
Thirteen-year social outcome among Nigerian outpatients with schizophrenia
Gureje, O., & Bamidele, R. (1999) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050126 · Cited by 50
Moncrieff, J., Gupta, S., & Horowitz, M. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320937910 · Cited by 43
Stability and prediction of schizophrenia from adolescence to adulthood
Helgeland, M. I., & Torgersen, S. (2005) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-005-0436-0 · Cited by 35
Social exclusion in schizophrenia: Psychological and cognitive consequences
Reddy, L. F., Irwin, M. R., Breen, E. C., Reavis, E. A., & Green, M. F. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.010 · Cited by 23
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1994-10-01
- Volume
- 151
- Issue
- 10
- Pages
- 1409-1416
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2419330808
- Cited by
- 762
- References
- 27
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.